The FDA has given emergency use authorization to remdesivir to treat hospitalized COVID-19 patients, President Trump said. The news comes days after preliminary results from a study of the drug showed it can help patients recover faster.
Rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States.Rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States.The Food and Drug Administration has given emergency use authorization to the antiviral drug remdesivir to treat hospitalized patients with the coronavirus, President Trump on Friday told reporters at the White House.
Gilead CEO Daniel O'Day said remdesivir maker Gilead Sciences is donating 1.5 million vials of the drug and will work with the federal government to distribute it to patients in need.of the drug showed it can help patients recover faster. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, hailed the findings earlier this week as"quite good news.
The authorization means remdesivir can be distributed in the U.S. and given intravenously to treat COVID-19 patients – both adults and children – who are hospitalized with severe disease,. The agency defines that category as"patients with low blood oxygen levels or needing oxygen therapy or more intensive breathing support such as a mechanical ventilator."
Discussing the findings about the drug's ability to help COVID-19 patients, O'Day cautioned earlier Friday that remdesivir is used to treat advanced cases, in which people are already hospitalized. The recent positive findings, he said, are a starting point in the fight against the respiratory disease.."Clearly with other medicines and vaccines to come, this is part, I think — the beginning of our ability to make an impact on this devastating virus.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA Issues Emergency Use Authorization For Gilead’s Coronavirus Treatment RemdesivirRemdesivir can now be administered intravenously by healthcare providers in the U.S. as it undergoes further study.
Leer más »
FDA grants Gilead’s remdesivir emergency authorization for COVID-19 treatmentThe authorization means that the drug can be used by hospitalized patients with suspected or laboratory-confirmed cases of COVID-19 outside of clinical trials or on a compassionate use basis
Leer más »
US FDA may announce emergency use of Gilead's coronavirus drugExperimental drug has proved effective against the new coronavirus in a major study, shortening the time it takes for patients to recover by four days on average, US government and company officials say.
Leer más »
FDA Issues Emergency Approval For Coronavirus Treatment DrugBREAKING: The Food and Drug Administration has approved the experimental drug remdesivir for treating coronavirus patients.
Leer más »
FDA Issues Emergency Approval For Coronavirus Treatment DrugBREAKING: The Food and Drug Administration has approved the experimental drug remdesivir for treating coronavirus patients.
Leer más »